Drug-related problems at discharge: results on the Spanish pharmacy discharge programme CONSULTENOS
| Autor: | MaÁngeles Pardo López, Ma Teresa Aznar Saliente, Enrique Soler Company, Ana Garcia Monsalve, Marta Aparício Cueva, Elena Arroyo Domingo, Monica Montero Hernández, Carmen Carrión Carrión, Monica Climente Martí, Nuria Bujaldón Querejeta, Joaquín Borrás Blasco, Amparo Rocher Milá |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Adult
Male Drug-Related Side Effects and Adverse Reactions Psychological intervention Pharmaceutical Science Pharmacy medicine Humans Hospital pharmacy Adverse effect Aged Patient discharge business.industry Health Policy Public Health Environmental and Occupational Health Middle Aged medicine.disease Patient Discharge Pharmaceutical care Female Observational study Medical emergency Educational interventions Pharmacy Service Hospital business |
| Zdroj: | International Journal of Pharmacy Practice. 18:297-304 |
| ISSN: | 2042-7174 0961-7671 |
| DOI: | 10.1111/j.2042-7174.2010.00054.x |
| Popis: | Objectives The aim of this study was to describe the most common drug-related problems (DRPs) found after discharge, pharmacist interventions and their results for the patients enrolled on the CONSULTENOS programme. Methods An observational, prospective, multicentre study was conducted to evaluate the results of a pharmaceutical care programme at discharge. Patients from 10 hospitals participating in the CONSULTENOS programme were enrolled. Pharmacists conducting this programme were newly graduated and worked under the supervision of a pharmacy staff member; only two pharmacists had previous hospital pharmacy experience. DRPs were identified and classified according to the Iaser methodology. Frequencies, types of DRP, interventions and outcomes were registered prospectively, at discharge and during a follow-up call 7 days after leaving the hospital. Key findings A total of 7711 patients were included in the study. DRPs were detected in 23.7% of the patients, with a total of 2120 DRPs (1788 at discharge and 332 in the follow-up). The most common problems identified at discharge were twofold: firstly the need of an additional treatment (34.1%) and secondly an unnecessary treatment (18.1%). In the follow-up phone call the most frequent DRPs were adverse effects (29.2%). Besides the standard educational interventions at discharge, 3313 extra interventions were performed, of which 85% were accepted. The outcomes for the patients were positive in 80% of the cases, although documentation with objective or subjective data was rare. Conclusions DRPs occur frequently after patient discharge. A pharmaceutical care programme can identify and solve DRPs in this scenario. The clinical impact of the pharmacists' interventions should be better addressed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text